Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China
· Delayed Price · Currency is CNY 19.83
+0.63 (3.28%)
Apr 29, 2026, 3:13 PM CST
SHE:300497 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 1,309 | 1,185 | 1,173 | 1,597 | 1,633 | 1,388 | Upgrade
|
| Other Revenue | - | - | 4.88 | 12.39 | 14.28 | 41.15 | Upgrade
|
| Revenue | 1,309 | 1,185 | 1,178 | 1,610 | 1,647 | 1,430 | Upgrade
|
| Revenue Growth (YoY) | 22.21% | 0.61% | -26.83% | -2.28% | 15.23% | -4.25% | Upgrade
|
| Cost of Revenue | 1,009 | 986.85 | 1,124 | 1,471 | 1,433 | 996.18 | Upgrade
|
| Gross Profit | 299.85 | 198.14 | 53.88 | 138.32 | 214.38 | 433.36 | Upgrade
|
| Selling, General & Admin | 161.28 | 153.03 | 152.9 | 193.55 | 179.91 | 163.47 | Upgrade
|
| Research & Development | 58.42 | 59.5 | 74.66 | 97.45 | 77.45 | 78.51 | Upgrade
|
| Other Operating Expenses | 3.77 | -22.96 | 16.59 | 16.53 | 15.23 | 14.58 | Upgrade
|
| Operating Expenses | 223.47 | 189.57 | 243.27 | 308.44 | 273.38 | 260.29 | Upgrade
|
| Operating Income | 76.39 | 8.57 | -189.4 | -170.12 | -59 | 173.07 | Upgrade
|
| Interest Expense | -0.05 | - | -40.58 | -42.03 | -41.1 | -24.92 | Upgrade
|
| Interest & Investment Income | - | - | 6.68 | 9.29 | 23.29 | 16.4 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 8.29 | 7.9 | 18.81 | -3.81 | Upgrade
|
| Other Non Operating Income (Expenses) | -67.85 | -48.25 | -2.48 | -4.54 | -3.51 | -0.21 | Upgrade
|
| EBT Excluding Unusual Items | 8.48 | -39.68 | -217.49 | -199.5 | -61.5 | 160.53 | Upgrade
|
| Impairment of Goodwill | - | - | - | -1.15 | -1.07 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.23 | -13.82 | -13.99 | -15.5 | -82.93 | -131.99 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.38 | -0.38 | -0.1 | 0.08 | 0.41 | -0.06 | Upgrade
|
| Asset Writedown | -7.6 | -11.33 | -101.63 | -23.74 | -12.82 | -2.01 | Upgrade
|
| Other Unusual Items | - | - | 44.65 | 6.64 | 15.21 | 28.61 | Upgrade
|
| Pretax Income | -13.73 | -65.21 | -288.56 | -233.17 | -142.71 | 55.07 | Upgrade
|
| Income Tax Expense | -9.6 | -2.24 | -8.11 | -9.91 | 21.47 | 15.53 | Upgrade
|
| Earnings From Continuing Operations | -4.12 | -62.97 | -280.45 | -223.26 | -164.17 | 39.54 | Upgrade
|
| Minority Interest in Earnings | 8.05 | 7.94 | 8.35 | 22.46 | 22.7 | 9.29 | Upgrade
|
| Net Income | 3.93 | -55.03 | -272.1 | -200.8 | -141.47 | 48.83 | Upgrade
|
| Net Income to Common | 3.93 | -55.03 | -272.1 | -200.8 | -141.47 | 48.83 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -84.71% | Upgrade
|
| Shares Outstanding (Basic) | 545 | 550 | 534 | 543 | 544 | 543 | Upgrade
|
| Shares Outstanding (Diluted) | 545 | 550 | 534 | 543 | 544 | 543 | Upgrade
|
| Shares Change (YoY) | -1.19% | 3.14% | -1.69% | -0.26% | 0.29% | 17.25% | Upgrade
|
| EPS (Basic) | 0.01 | -0.10 | -0.51 | -0.37 | -0.26 | 0.09 | Upgrade
|
| EPS (Diluted) | 0.01 | -0.10 | -0.51 | -0.37 | -0.26 | 0.09 | Upgrade
|
| EPS Growth | - | - | - | - | - | -86.96% | Upgrade
|
| Free Cash Flow | -106.67 | -162.21 | 45.89 | -306.99 | -580.26 | -607.28 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.29 | 0.09 | -0.57 | -1.07 | -1.12 | Upgrade
|
| Gross Margin | 22.91% | 16.72% | 4.57% | 8.59% | 13.01% | 30.31% | Upgrade
|
| Operating Margin | 5.83% | 0.72% | -16.08% | -10.57% | -3.58% | 12.11% | Upgrade
|
| Profit Margin | 0.30% | -4.64% | -23.10% | -12.47% | -8.59% | 3.42% | Upgrade
|
| Free Cash Flow Margin | -8.15% | -13.69% | 3.90% | -19.07% | -35.23% | -42.48% | Upgrade
|
| EBITDA | 268.15 | 196.12 | -18.68 | -10.66 | 64.84 | 271.64 | Upgrade
|
| EBITDA Margin | 20.48% | 16.55% | -1.59% | -0.66% | 3.94% | 19.00% | Upgrade
|
| D&A For EBITDA | 191.77 | 187.56 | 170.72 | 159.46 | 123.84 | 98.57 | Upgrade
|
| EBIT | 76.39 | 8.57 | -189.4 | -170.12 | -59 | 173.07 | Upgrade
|
| EBIT Margin | 5.83% | 0.72% | -16.08% | -10.57% | -3.58% | 12.11% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 28.20% | Upgrade
|
| Revenue as Reported | - | - | 1,178 | 1,610 | 1,647 | 1,430 | Upgrade
|
| Advertising Expenses | - | - | 4.05 | 6.19 | - | 4.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.